Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heme Arginate in Deceased Donor Kidney Transplant
NCT01430156Phase 3Completed
- Sponsor
- University of Edinburgh
- Start
- Jan 2012
- Primary completion
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heme arginate in ischemia-reperfusion injury (IRI), Graft failure, sponsored by University of Edinburgh. Started Jan 2012; status: completed.
02
Drugs
heme arginate
03
Conditions
ischemia-reperfusion injury (IRI)Graft failure
Beyond the preview
Go deeper on NCT01430156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430156.